Artwork
iconShare
 
Manage episode 494661502 series 3590090
Content provided by Jeremy Stanley. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Jeremy Stanley or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

We dive into the latest research on ketamine's therapeutic potential, including its role in treating ischemic stroke, postoperative cognitive dysfunction (POCD), and PTSD. You'll hear how scientists are studying its effects on brain regions like the hippocampus and amygdala, as well as its impact on neuroinflammation, fear memory, and neurogenesis.

We'll also explore ketamine’s use in anesthesia, its interactions with drugs like oral morphine, and how it's monitored using tools like EEG. From molecular techniques like RT-qPCR and Western blotting to real-world applications—this episode breaks down the science driving ketamine's future in medicine.

Here’s some of what you’ll hear in this episode:

🧠 Ketamine’s impact on brain function, cognition, and EEG readings
🧬 NMDA receptors, BDNF, cytokines & other molecular targets
📉 How ketamine may raise delirium risk in cognitively impaired patients
🧪 In vitro studies on ketamine’s anti-inflammatory and anticancer potential
📊 Why EEG interpretation—not just BIS numbers—matters for patient safety

Visit us online: https://beyondthemaskpodcast.com/

The 1099 CRNA Institute: https://aana.com/1099

Get the CE Certificate here (and directly submit to the NBCRNA): https://beyondthemaskpodcast.com/wp-content/uploads/2020/04/Beyond-the-Mask-CE-Cert-FILLABLE.pdf

Help us grow by leaving a review: https://podcasts.apple.com/us/podcast/beyond-the-mask-innovation-opportunities-for-crnas/id1440309246

Donate to Our Heart Your Hands here: https://www.ourheartsyourhands.org/donate

  continue reading

428 episodes